The threat of tariffs has loomed large over U.S. equities. Investors and strategists warn that high levies can reignite ...

US stocks slipped on Friday afternoon, with carmakers and Chinese companies leading the decline, as the White House said ...

RBC Capital analyst Craig Wong-Pan maintained a Hold rating on Resmed (RMD – Research Report) on January 29 and set a price target of $238.00.

Imposing higher capital requirements on UBS as a systemically relevant bank will usher in higher costs for companies and ...

That helps underscore UBS analyst Joseph Spak's belief that investors don't really view Tesla (TSLA) as a carmaker any more. "We can almost definitively say the market doesn't treat TSLA like an auto ...

RBC Capital analyst Nik Modi maintained a Hold rating on Energizer Holdings (ENR – Research Report) today and set a price target of $38.00. The ...

UBS analyst Susy Tibaldi updated the financial outlook for EssilorLuxottica SA (EL:FP) (OTC: OTC:ESLOY), increasing the price ...

HSBC is preparing to wind down its M&A and equity capital markets businesses in Europe, the UK and the Americas as part of a ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Key stocks in the Dow Jones Industrial Average (DJIA), including McDonald’s, JPMorgan, and Goldman Sachs. Analyze ratings, ...

On Friday, Exelixis Inc (EXEL) stock saw a decline, ending the day at $32.38 which represents a decrease of $-1.75 or -5.13% from the prior close of $34.13. The stock opened at $33.49 and touched a ...

With a trading volume of 5,249,687, the price of ABT is down by -0.19%, reaching $122.98. Current RSI values indicate that ...